BR9802537A - Método para anestesiar um paciente humano antes de cirurgias de porte dose unitária e sistema farmacêutico para administração - Google Patents

Método para anestesiar um paciente humano antes de cirurgias de porte dose unitária e sistema farmacêutico para administração

Info

Publication number
BR9802537A
BR9802537A BR9802537A BR9802537A BR9802537A BR 9802537 A BR9802537 A BR 9802537A BR 9802537 A BR9802537 A BR 9802537A BR 9802537 A BR9802537 A BR 9802537A BR 9802537 A BR9802537 A BR 9802537A
Authority
BR
Brazil
Prior art keywords
administration
surgery
anesthetize
dose
human patient
Prior art date
Application number
BR9802537A
Other languages
English (en)
Portuguese (pt)
Inventor
Lawrence E Mather
John Mcglashan Richards
Original Assignee
Darwin Discovery Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9715462.9A external-priority patent/GB9715462D0/en
Priority claimed from GBGB9722022.2A external-priority patent/GB9722022D0/en
Priority claimed from GBGB9810427.6A external-priority patent/GB9810427D0/en
Application filed by Darwin Discovery Ltd filed Critical Darwin Discovery Ltd
Publication of BR9802537A publication Critical patent/BR9802537A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P23/00—Anaesthetics
    • A61P23/02—Local anaesthetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Anesthesiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Electrotherapy Devices (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
BR9802537A 1997-07-22 1998-07-21 Método para anestesiar um paciente humano antes de cirurgias de porte dose unitária e sistema farmacêutico para administração BR9802537A (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9715462.9A GB9715462D0 (en) 1997-07-22 1997-07-22 levobupivacaine and its use
GBGB9722022.2A GB9722022D0 (en) 1997-10-17 1997-10-17 Levobupivacaine and its use
GBGB9810427.6A GB9810427D0 (en) 1998-05-14 1998-05-14 Levobupivacaine and its use

Publications (1)

Publication Number Publication Date
BR9802537A true BR9802537A (pt) 1999-07-20

Family

ID=27268945

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9802537A BR9802537A (pt) 1997-07-22 1998-07-21 Método para anestesiar um paciente humano antes de cirurgias de porte dose unitária e sistema farmacêutico para administração

Country Status (12)

Country Link
US (2) US6069155A (enExample)
EP (1) EP0998287B1 (enExample)
JP (1) JP2001510795A (enExample)
AT (1) ATE239474T1 (enExample)
AU (1) AU739510B2 (enExample)
BR (1) BR9802537A (enExample)
CA (1) CA2294921C (enExample)
DE (1) DE69814394T2 (enExample)
DK (1) DK0998287T3 (enExample)
ES (1) ES2198731T3 (enExample)
PT (1) PT998287E (enExample)
WO (1) WO1999004772A2 (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6376754B1 (en) * 1997-03-07 2002-04-23 Asgrow Seed Company Plants having resistance to multiple herbicides and its use
AU752802C (en) 1997-11-14 2006-04-13 Pacira Pharmaceuticals, Inc. Production of multivesicular liposomes
WO2000003660A1 (en) 1998-07-17 2000-01-27 Skyepharma, Inc. Biodegradable compositions for the controlled release of encapsulated substances
WO2001070322A1 (en) * 2000-03-24 2001-09-27 Stephen Brushey Anesthesia conduction catheter
US7805188B2 (en) * 2000-03-24 2010-09-28 Micor, Inc. Anesthesia conduction catheter for delivery of electrical stimulus
BR0002246A (pt) * 2000-04-06 2003-04-15 Cristalia Prod Quimicos Farm Processo de obtenção dos enantiÈmeros da bupivacaìna racêmica, processo de obtenção de composições farmacêuticas a base de levobupivacaìna: composições farmacêuticas a base de levobupivacaìna formuladas nas formas básicas ou sais farmaceuticamente aceitáveis e utilização das composições farmacêuticas a base de levobupivacaìna formuladas nas formas básicas ou sais farmaceuticamente aceitáveis
WO2002096368A2 (en) * 2001-05-31 2002-12-05 Skyepharma Inc. Encapsulation of nanosuspensions in liposomes and microspheres
US20070196415A1 (en) * 2002-11-14 2007-08-23 Guohua Chen Depot compositions with multiple drug release rate controls and uses thereof
AU2002359407B2 (en) * 2001-11-14 2008-02-28 Durect Corporation Catheter injectable depot compositions and uses thereof
US20040001889A1 (en) 2002-06-25 2004-01-01 Guohua Chen Short duration depot formulations
CN1684663A (zh) 2002-07-31 2005-10-19 阿尔萨公司 可注射的多模式聚合物储库组合物以及其用途
WO2004012703A1 (en) * 2002-07-31 2004-02-12 Alza Corporation Injectable depot compositions and uses thereof
WO2004060147A2 (en) * 2002-12-31 2004-07-22 The Board Of Trustees Of The University Of Illinois Tissue and organ preservation, protection and resuscitation
US20060142234A1 (en) * 2004-12-23 2006-06-29 Guohua Chen Injectable non-aqueous suspension
WO2015088990A1 (en) 2013-12-09 2015-06-18 Durect Corporation Pharmaceutically active agent complexes, polymer complexes, and compositions and methods involving the same
WO2021146215A1 (en) 2020-01-13 2021-07-22 Durect Corporation Sustained release drug delivery systems with reduced impurities and related methods
CA3203561A1 (en) 2021-01-12 2022-07-21 Adrian Neil Verity Sustained release drug delivery systems and related methods
US11278494B1 (en) 2021-01-22 2022-03-22 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12151024B2 (en) 2021-01-22 2024-11-26 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11033495B1 (en) 2021-01-22 2021-06-15 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US11357727B1 (en) 2021-01-22 2022-06-14 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12285419B2 (en) 2021-10-14 2025-04-29 Pacira Pharmaceuticals, Inc. Bupivacaine multivesicular liposome formulations and uses thereof
US12070454B1 (en) 2022-05-05 2024-08-27 Pfof Llc Anesthetic nerve block and method
CN119677554A (zh) 2022-05-05 2025-03-21 普络夫有限责任公司 麻醉神经阻滞和方法
US12156940B1 (en) 2024-05-20 2024-12-03 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12251472B1 (en) 2024-05-20 2025-03-18 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes
US12280149B1 (en) 2024-05-20 2025-04-22 Pacira Pharmaceuticals, Inc. Manufacturing of bupivacaine multivesicular liposomes

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4695576A (en) * 1984-07-09 1987-09-22 Astra Lake Medel Aktiebolag L-N-n-propylpipecolic acid-2,6-xylidide
AU694453B2 (en) * 1993-10-13 1998-07-23 Darwin Discovery Limited Analgesic agent and its use
GB9321061D0 (en) * 1993-10-13 1993-12-01 Chiroscience Ltd Analgestic agent and its use
US5849763A (en) * 1993-10-13 1998-12-15 Darwin Discovery Limited Use of levobupivacaine as an anesthetic agent
CA2216583C (en) * 1995-04-13 2007-10-30 Chiroscience Limited Levobupivacaine and its use as an anaesthetic in pregnant women
GB9704352D0 (en) * 1997-03-03 1997-04-23 Chiroscience Ltd Levobupivacaine and its use

Also Published As

Publication number Publication date
DE69814394T2 (de) 2004-03-11
PT998287E (pt) 2003-09-30
JP2001510795A (ja) 2001-08-07
ES2198731T3 (es) 2004-02-01
US6514994B2 (en) 2003-02-04
EP0998287B1 (en) 2003-05-07
DK0998287T3 (da) 2003-09-01
AU8452898A (en) 1999-02-16
AU739510B2 (en) 2001-10-11
EP0998287A2 (en) 2000-05-10
US6069155A (en) 2000-05-30
US20020016338A1 (en) 2002-02-07
CA2294921A1 (en) 1999-02-04
WO1999004772A2 (en) 1999-02-04
WO1999004772A3 (en) 1999-04-08
DE69814394D1 (de) 2003-06-12
CA2294921C (en) 2009-04-07
ATE239474T1 (de) 2003-05-15

Similar Documents

Publication Publication Date Title
BR9106114A (pt) Metodo para tratar ou prevenir uma doenca auto-imune (ad) e formulacao farmaceutica
NO20022014L (no) En fast oral kontrollert frigjorende doseringsform inneholdende hydrokodon
BR0109446A (pt) Medicamento para a aplicação intracorpórea, uso de um xanteno halogenado, composição farmacêutica, e, método de tratamento
PT998287E (pt) Utilizacao de levobupivacaina
DK0759757T3 (da) Orale, væskeformige alendronatformuleringer
BR9909192A (pt) Preparações galênicas de meloxicam para administração oral
ES2162615T3 (es) Metodo para tratar o prevenir diabetes de tipo 1 mediante la administracion oral de insulina.
MX9709644A (es) Dispositivo para el suministro transdermico por electrotransporte de fentanilo y sufentanilo.
ES2191329T3 (es) Utilizacion de xantofilos en medicamentos para la mejora de la duracion de la funcion muscular o el tratamiento de trastornos o enfermedades musculares.
BR9306042A (pt) Método para tratar uma doença auto-immune em um mamifero e formas de dosagens farmacêuticas oral e inalável
ATE292982T1 (de) Analgesiche synergie durch gleichzeitige verabreichung von subanalgesichen doseneines mu- opioidanagonisten und eines kappa - 2- opioidanagonisten
DE69831869D1 (de) Verbesserte verabreichungstechnik für multiple medikamentengaben
ATE235895T1 (de) Arzneistoff-abgabesystem enthaltend eine festgepackte, feste arzneistoffbasis
ATE165000T1 (de) Dosierungsform zur verzoegerten wirkstofffreisetzung
PT957899E (pt) Forma de dosagem para proporcionar um medicamento numa dose crescente
ATE202926T1 (de) Pharmazeutische brausepräparate enthaltend bioabbaubare mikrokapseln zur kontrolierten wirkstofffreisetzung
PT1083879E (pt) Metodos e dispositivos para proporcionar uma terapia de drogas prolongada
NO994165L (no) Anvendelse av deskarboetoksyloratadin for fremstilling av et medikament for behandling av urininkontinens, reisesyke og svimmelhet
DE69200711D1 (de) Pharmazeutische Zusammensetzungen enthaltend Fluticasonpropionat und Oxikonazol oder dessen Salz zur lokalen Anwendung.
GR3032224T3 (en) Therapeutic agent for threatened abortion.
GB9930075D0 (en) Medicaments
BR0104586A (pt) Método para tratamento de neurodegeneração
FR2818147B1 (fr) Nouvelle application therapeutique d'un derive de la thienyclyclohexylamine
DE59908258D1 (de) Blister enthaltend ein transdermales therapeutisches system und eine einzeldosierte darreichungsform
IL110888A0 (en) Pharmaceutical compositions for the treatment of liver diseases comprising a benzothiazepine derivative

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: INDEFERIMENTO DO PRESENTE PEDIDO, UMA VEZ QUE ESTE NAO APRESENTA CONDICOES DE PATENTEABILIDADE

B12B Appeal against refusal [chapter 12.2 patent gazette]